Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The primary objective of this study is to assess the safety of 2 rivaroxaban treatment strategies and a dose-adjusted VKA treatment strategy after PCI (with stent placement) in subjects with paroxysmal, persistent, or permanent non-valvular AF, based on the composite of TIMI major bleeding, minor bleeding, and bleeding requiring medical attention events (known collectively as clinically significant bleeding) after 12 months of therapy.
Critère d'inclusion
- Prevention of stroke and non-CNS systemic embolism in patients with nonvalvular atrial fibrillation who undergo percutaneous coronary intervention